Renal Infarction From Over-the-Counter Testosterone Booster Pills: A Case Report
Abstract
Renal infarction is a challenging diagnosis that usually requires a high level of clinical suspicion because its clinical presentation is often attributed to more frequent causes. Here, we present the case of a young male with right flank pain. A computed tomography (CT) of the abdomen ruled out nephrolithiasis; hence, a CT urogram was performed, which revealed an acute right kidney infarction. The patient had no personal or family history of clotting disorders. Subsequent tests for atrial fibrillation, an intracardiac shunt, and genetic causes were negative, and a presumptive diagnosis of a hypercoagulable state from over-the-counter testosterone supplements was made.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents
- On model selections for repeated measurement data in clinical studies
- Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells
- Region-specific microRNA signatures in the human epididymis
- Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety
- In Vitro characterization of the endocrine disrupting effects of per- and poly-fluoroalkyl substances (PFASs) on the human androgen receptor
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.